𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis

✍ Scribed by Fady Daniel; Marie-Anne Loriot; Philippe Seksik; Jacques Cosnes; Jean-Marc Gornet; Marc Lémann; Francine Fein; Gwenola Vernier-Massouille; Martine De Vos; Arnaud Boureille; Xavier Treton; Bernard Flourié; Xavier Roblin; Edouard Louis; Frank Zerbib; Philippe Beaune; Philippe Marteau


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
86 KB
Volume
13
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

✦ Synopsis


Background: Cyclosporine A (CsA) is inconstantly effective in inducing remission in acute attacks of ulcerative colitis (UC) not responding to steroids. This study aimed to establish whether multidrug resistance gene (MDR)1 polymorphisms would be associated with CsA failure.

Patients and Methods:

The distribution of the different genotypes of single nucleotide polymorphisms (SNP) G2677T/A and C3435T of MDR1 exons 21 and 26, respectively, was studied in 154 patients (mean age, 44 yr) who had received CsA to treat severe attacks of steroid resistant UC in 11 centers in France and Belgium. Patients were classified as CsA failure (n ϭ 50) when they needed colectomy within 30 days after CsA initiation. The SNPs were detected by use of a 5Ј nuclease allelic discrimination assay.

Results:

There was a significant association between the G2677T/A polymorphism distribution (exon 21) and the risk for CsA failure (P ϭ 0.0001). The TT genotype of exon 21 was significantly associated with the risk compared with the two other genotypes (odds ratio, 3.77; 95% confidence interval, 1.42-9.97, P ϭ 0.007). There was no significant association between the genotype C3435T distribution (exon 26) and the risk of CsA failure (P ϭ 0.23).

Conclusion:

The TT genotype of exon 21 MDR1 polymorphisms is associated with a higher risk of CsA failure in patients with steroid resistant UC. Further studies should be performed to establish whether other treatments could be more efficient to avoid surgery in this subset of patients.


📜 SIMILAR VOLUMES


Genetic variation and response to morphi
✍ Joy R. Ross; Julia Riley; Annie B. Taegetmeyer; Hiroe Sato; Sophy Gretton; Rolan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract ## BACKGROUND Pain is a common symptom for patients with cancer, and opioids are the treatment of choice for moderate or severe cancer‐related pain. Central side effects, such as drowsiness, confusion, and hallucinations, can limit the use of opioids in clinical practice. ## METHODS

Drug resistance mutations and newly reco
✍ Carlo Torti; Eugenia Quiros-Roldan; Laura Monno; Andrea Patroni; Annalisa Saraci 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract This study aimed at identifying HIV‐1 protease amino acid changes associated with protease inhibitor (PI) exposure and susceptibility. New amino acid substitutions were correlated with the number of experienced PIs, reaching statistical significance only for those at positions 3, 44, an